| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 05/06/2004 | EP1414964A2 Vegf isoform |
| 05/06/2004 | EP1414963A2 Lipid-associated molecules |
| 05/06/2004 | EP1414948A2 Inhibition of apoptosis process and improvement of cell performance |
| 05/06/2004 | EP1414862A1 Anti-idiotypic antibodies of hla class i molecules and the use thereof in the preparation of compositions that are designed to inhibit vascular activation |
| 05/06/2004 | EP1414861A2 Humanized antibodies against icam-1, their production and uses |
| 05/06/2004 | EP1414860A2 Pan-specific monoclonal antibody |
| 05/06/2004 | EP1414859A2 Anti-ssrp-1 monoclonal antibodies and hybridomas producing said antibodies |
| 05/06/2004 | EP1414858A2 Single chain camelid vhh antibodies, method for their production in a mammal, and their uses |
| 05/06/2004 | EP1414852A2 Human secreted proteins, their encoding pulynucleotides, and uses thereof |
| 05/06/2004 | EP1414851A2 Cellular virus receptors and methods of use. |
| 05/06/2004 | EP1414495A1 Anti-microbial targeting chimeric pharmaceutical |
| 05/06/2004 | EP1414494A1 Inhibitors of her3 activity |
| 05/06/2004 | EP1414493A2 Oral immunoglobulin treatment for inflammatory bowel disease |
| 05/06/2004 | EP1414492A1 Method for treating multiple myeloma |
| 05/06/2004 | EP1414491A2 Methods of inhibiting amyloid toxicity |
| 05/06/2004 | EP1414477A2 Repeat sequences of the ca125 gene and their use for diagnostic and therapeutic interventions |
| 05/06/2004 | EP1414471A2 Therapeutic agents comprising pro-apoptotic proteins |
| 05/06/2004 | EP1352085A4 P2y purinergic receptor expression for identifying preneoplastic and neoplastic states |
| 05/06/2004 | EP0991945B1 Method for identification of tumor antigens with autoantibodies in serum |
| 05/06/2004 | EP0960212A4 Gene identification method |
| 05/06/2004 | EP0889955B1 Recombinant phages |
| 05/06/2004 | EP0868197B1 Anti-l-selectin antibodies for prevention of multiple organ failure and acute organ damage |
| 05/06/2004 | EP0589004B2 Process for the determination of peptides corresponding to immunologically important epitopes of hcv |
| 05/06/2004 | CA2503679A1 Methods for determining genetic resistance of pigs to diseases caused by rna viruses |
| 05/06/2004 | CA2503315A1 Procedure for obtaining cell lines in a protein-free media and cell line obtained by the method |
| 05/06/2004 | CA2503026A1 Antibody and utilization of the same |
| 05/06/2004 | CA2502663A1 Methods to prevent tumor recurrence by blockade of tgf-.beta. |
| 05/06/2004 | CA2500490A1 Neutralizing antibodies against gdf-8 and uses therefor |
| 05/06/2004 | CA2497909A1 Low dose methods for treating disorders in which tnf.alpha. activity is detrimental |
| 05/06/2004 | CA2482744A1 Hiv envelope-cd4 complexes and hybrids |
| 05/06/2004 | CA2468903A1 Endogenous retrovirus up-regulated in prostate cancer |
| 05/05/2004 | CN1494591A Polynucleotide useful for modulating cancer cell proliferation |
| 05/05/2004 | CN1494554A Natural HIV virus antibody |
| 05/05/2004 | CN1494553A Modified antibodies and method of use |
| 05/05/2004 | CN1494552A Flt 4 (VEGFR-3) as target for tumor imaging and anti-tumor therapy |
| 05/05/2004 | CN1494433A Use of CD 23 antagonists for treatment of neoplastic disorders |
| 05/05/2004 | CN1493690A Polypeptide-human protein metabolic enzyme 29 and polynucleotide for coding said polypeptide |
| 05/05/2004 | CN1493597A Separation dendron shaped cell membrane protein gene |
| 05/05/2004 | CN1493596A Polypeptide-human programming cell death protein 22 and polynucleotide for coding said polypeptide |
| 05/05/2004 | CN1493595A Polypeptide-human tumour protein 20 and polynucleotide for coding said polypeptide |
| 05/05/2004 | CN1493594A Polypeptide-human signal peptide secretory protein I 10 and polynucleolide for coding said polypeptide |
| 05/05/2004 | CN1493593A Polypeptide-human transcription regulate and control protein 44 and polynucleotide for coding said polypeptide |
| 05/05/2004 | CN1493592A Polypeptide-respiratory protein 18 and polynucleotide for coding said polypeptide |
| 05/05/2004 | CN1493591A Polypeptide-human protein synthetic protein L14, 22 and nucleotide for coding said polypeptide |
| 05/05/2004 | CN1493590A Polypeptide-human cell disintegrate regulatory protein 27 and polynucleotide for coding said polypeptide |
| 05/05/2004 | CN1493589A Polypeptide-human cell regulate and control protein 54 and polynucleotide for coding said polypeptide |
| 05/05/2004 | CN1493588A Polyepeptide-human transcription regulate and control protein 35 and polynucleotide for coding said polypeptide |
| 05/05/2004 | CN1493587A Polypeptide-human protein regulatory protein s9 and polynucleotide for coding said polypeptide |
| 05/05/2004 | CN1493586A Polypeptide-human transcription regulate and control protein 38 and polynucleotide for coding said polypeptide |
| 05/05/2004 | CN1493585A Polypeptide-human tubulin monomer releasing factor 28 and polynucleotide for coding said polypeptide |
| 05/05/2004 | CN1493584A New polypeptide-human tumour inhibiting factor 46 and polynucleotide for coding said polypeptide |
| 05/05/2004 | CN1493583A New polypeptide-hyman glucoprotein 42 and polynucleotide for coding said polypeptide |
| 05/05/2004 | CN1148577C Antibodies and SCFV immunotoxins specific to improted fire ants, and their application |
| 05/05/2004 | CN1148450C Recombinant proteinse of a Pakistani Strain of Hepatitis E and their use in diagnostic methods and vaccines |
| 05/05/2004 | CN1148382C Cathepsin O2 protease |
| 05/05/2004 | CN1148381C New human chemotaxis factor macrophage inflammatory protein, its coding sequence and use |
| 05/04/2004 | US6730778 Nucleotide sequences coding polypeptide for use in the treatment of nervous system disorders |
| 05/04/2004 | US6730777 Cystic fibrosis gene |
| 05/04/2004 | US6730658 Stimulation of lymphatic growth with an FLT4 ligand |
| 05/04/2004 | US6730505 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
| 05/04/2004 | US6730491 Nucleotide sequences coding an enzymatic polypeptide for use in the treatment of cell proliferative or differentiative, nervous system, immune, cardiovascular, liver and skin disorders |
| 05/04/2004 | US6730489 Antibodies to truncated VEGF-D and uses thereof |
| 05/04/2004 | US6730488 Immunoassay for detecting preferential enzymatic polypeptide in sample |
| 05/04/2004 | US6730486 Human βTrCP protein |
| 05/04/2004 | US6730483 Phagemid for antibody screening |
| 05/04/2004 | US6730480 Sphingosine kinase enzyme |
| 05/04/2004 | US6730477 Includes measuring levels of a breast specific gene (bsg) in cells, tissues or bodily fluids in a patient and comparing to a normal human control |
| 05/04/2004 | US6730307 Monoclonal antibody |
| 05/04/2004 | US6730304 Viral nuceotide sequences for use in the diagnosis of viral diseases |
| 05/04/2004 | US6730300 Humanization of an anti-carcinoembryonic antigen anti-idiotype antibody and use as a tumor vaccine and for targeting applications |
| 05/04/2004 | US6730296 Receptor agonists and antagonists |
| 05/04/2004 | CA2296178C Human intestinal npt2b |
| 05/04/2004 | CA2080226C Cd4-gamma2 and cd4-igg2 chimeras |
| 04/29/2004 | WO2004036258A2 Screening antibodies using an optical fiber array device capable of simultaneously performing multiple functional assays |
| 04/29/2004 | WO2004036257A2 Screening compound libraries using an optical fiber array device capable of simultaneously performing multiple functional assays |
| 04/29/2004 | WO2004036222A1 ANTIBODIES REACTIVE WITH β (1-3) -GLUCANS |
| 04/29/2004 | WO2004035788A1 Novel genes and proteins encoded thereby |
| 04/29/2004 | WO2004035787A2 Transplantable cell with immune modulator |
| 04/29/2004 | WO2004035777A1 Adipocyte differentiation-associated genes and proteins |
| 04/29/2004 | WO2004035752A2 ALTERATION OF FcRn BINDING AFFINITIES OR SERUM HALF-LIVES OF ANTIBODIES BY MUTAGENESIS |
| 04/29/2004 | WO2004035747A2 Human anti-ifn-ϝ neutralizing antibodies as selective ifn-ϝ pathway inhibitors |
| 04/29/2004 | WO2004035742A2 Sets of digital antibodies directed against short epitopes, and methods using same |
| 04/29/2004 | WO2004035628A1 Regulation o-if the cre recombinase using a dissociation/re association system of said recombinase |
| 04/29/2004 | WO2004035619A1 Compositions and methods for targeting antigen-presenting cells with antibody single-chain variable region fragments |
| 04/29/2004 | WO2004035611A2 Peptides binding the phosphatase 2a protein and polynucleotides encoding same |
| 04/29/2004 | WO2004035608A2 System and method for cleaving antibodies |
| 04/29/2004 | WO2004035607A2 Human monoclonal antibodies against cd20 |
| 04/29/2004 | WO2004035603A2 Erythropoietin receptor binding antibodies |
| 04/29/2004 | WO2004035537A2 Antibodies that bind cell-associated ca 125/o772p and methods of use thereof |
| 04/29/2004 | WO2004035199A1 Affinity adsorbents for immunoglobulins |
| 04/29/2004 | WO2004035078A1 Treatment of inflammatory bowel disease |
| 04/29/2004 | WO2004035003A2 Therapeutic adjuvant |
| 04/29/2004 | WO2004034988A2 Human anti-ifn-ϝ neutralizing antibodies as selective ifn-ϝ pathway inhibitors |
| 04/29/2004 | WO2004034981A2 Compositions and methods for inhibiting group b streptococcus-induced pulmonary hypertension in neonates |
| 04/29/2004 | WO2004034979A2 Monoclonal antibodies specific for cariogenic bacteria |
| 04/29/2004 | WO2004034974A2 Anti-reg iϝ antibody for treatment of colon cancer |
| 04/29/2004 | WO2004020606A9 Method of resisting osteoclast formation |
| 04/29/2004 | WO2004016151A3 Pthrp-derived modulators of smooth muscle proliferation |
| 04/29/2004 | WO2004014311A3 Nogo receptor antagonists |
| 04/29/2004 | WO2004007553A8 Antibodies anti-c5 component of the complement system and their use |